|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Gene expression studies of mRNAs encoding the NMDA receptor subunits NMDAR1, NMDAR2A, NMDAR2B, NMDAR2C, and NMDAR2D following long-term treatment with cis-and trans-flupenthixol as a model for understanding the mode of action of schizophrenia drug treatment显示文摘 | Chen AC McDonald B Moss SJ | 1998 | Brain Res Mol Brain Res1998，54，1： | 1 |
| 2 | Immunogenicity of aheptavalent conjugate pneumococcal vaccine administeredconcurrently with a combination diphtheria,tetanus,five-com-ponent acellular pertussis,inactivated polio,and Haemophilusinfluenzae type B vaccine and a meningococcal group Cconjugate vaccine at 2,3,and 4 months of age显示文摘 | Moss SJ Fenton AC Toomey J | 2010 | ClinVaccine Immunol2010，17，3： | 1 |
| 3 | In Silico promoter analysis can predict genes of functional relevance in cell proliferation: validation in a colon cancer model 显示文摘 | Moss AC Doran PP MacMathuna D | 2007 | Translational Oncogenomics2007，2，： | 1 |
| 4 | cAMP-dependent phosphorylation of the tetrodotoxinresistant voltage-dependent sodium channel SNS显示文摘 | Fitzgerald EM Okuse K Wood JN Dolphin AC Moss SJ | 1999 | J Physiol1999，516，2： | 1 |
| 5 | Impact of antibodies to inflix- imab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): A meta - analysis显示文摘 | Nanda KS Cheifetz AS Moss AC | 2013 | Am J Gastroenterol2013，108，1： | 1 |
| 6 | Mesalamine in the treatment and maintenance of remission of ulcer- ative colitis, 显示文摘 | Ham M Moss AC | 2012 | Expert review of clinical pharmacology2012，5，： | 1 |
| 7 | The risks and the benefits of mesalazine as a treatment for ulcerative colitis 显示文摘 | Moss AC Peppercorn MA | 2007 | Ex- pert Opin Drug Saf2007，6，2： | 1 |
| 8 | Mesalamine in the treatment and ma- intenance of remission of ulcerative colitis 显示文摘 | Ham M Moss AC | 2012 | Expert Rev Clin Pharmacol2012，5，2： | 1 |
| 9 | Efficacy ofmycophenolate mofetil as single-agent therapy for refractoryimmune thrombocytopenic purpura显示文摘 | Provan D Moss AJ Newland AC Bussel JB | 2006 | Am J Hematol2006，81，1： | 1 |
| 10 | Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura显示文摘 | Provan D Moss AJ Newland AC | | 0，，01： | 1 |
| 11 | The risks and the benefits of mesalazine as a treatment for ulcerative colitis显示文摘 | Moss AC Peppercorn MA | 2007 | Expert Opin Drug Saf2007，6，2： | 1 |
| 12 | Towards safer neonatal transfer: The importance of critical incident review 显示文摘 | Moss SJ Embleton ND Fenton AC | 2005 | Arch Dis Child2005，90，7： | 1 |
| 13 | Determination of liver and spleen volumes by computed tomography: an experiment study in dogs显示文摘 | Moss AA Friedman MA Btito AC | 1981 | T Comput Assist Tomogr1981，5，1： | 1 |
| 14 | Combined oral and topical mesalazine treatment for extensive ulcerative colitis 显示文摘 | Moss AC Cheifetz AS Peppercorn MA | 2006 | Nat Clin Pract Gastroenterol Hepatol2006，3，5： | 1 |
| 15 | Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a recta-analysis显示文摘 | NANDA KS CHEIFETZ AS MOSS AC | 2013 | Am J Gastroenterol2013，108，1： | 1 |
| 16 | Impact of antibodies to infliximab on clinical outcomes and serum iufliximab levels in patients with in- flammatory bowel disease (1BD) : a meta-analysis 显示文摘 | Nanda KS Cheifetz AS Moss AC | 2013 | Am J Gastro- enterol2013，108，1： | 1 |
| 17 | Annexin 11 is required for midbody formation and completion of the terminal phase of cytokinesis显示文摘 | Tomas AC Futter C Moss SE | 2004 | J Cell Biol2004，165，6： | 1 |
| 18 | Language-related cognitive declines after left temporal lobectomy in children显示文摘 | Dlugos DJ Moss EM Duhaime AC | 1999 | Pediatr Neurol1999，21，： | 1 |
| 19 | Steroid-refractory severe ulcerative colitis: what are the available treatment options 显示文摘 | Moss AC Peppercorn MA | 2008 | Drugs2008，68，9： | 1 |
| 20 | Antibodies to infliximab and risk of infusion reactions in patients with inflammatory bowel disease: a systematic review and recta- analysis显示文摘 | O' MEARA S NANDA KS MOSS AC | 2014 | Inflamm Bowel Dis2014，20，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员